Clinical Trials Logo

Clinical Trial Summary

This is a single-dose, open-label, randomized, three-way crossover study to assess the effect of food on the absorption and bioavailability of PBI-200.


Clinical Trial Description

This is a single-dose, open-label, randomized, three-way crossover study to assess the effect of food on the absorption and bioavailability of PBI-200, administered orally under fasted and fed conditions. The study will enroll 18 healthy adult volunteers to ensure study completion of at least 12 evaluable volunteers. The study will be conducted in 3 groups, with each group enrolling 6 volunteers. As this is a crossover study, each volunteer will serve as their own control. ;


Study Design


NCT number NCT05160389
Study type Interventional
Source Pyramid Biosciences
Contact
Status Completed
Phase Phase 1
Start date November 17, 2021
Completion date January 6, 2022